Simply Wall St User's Discussions - Simply Wall St

SI

Simply Wall St User

Community Contributor

Member since 2026

Views

0

Fair Values Set

0

Comments

2

Followers

0

No bio added yet

No link added

ELTX·2 days agoStudy on track for success

For me, one of the most interesting reference points would be the mFOLFIRINOX arm from the PRODIGE 24 trial (mDFS ~21 months). Considering that arm was enriched with fitter patients able to tolerate the treatment, and that Gem and GemCap are still widely used in real-world practice, it probably wouldn’t be unreasonable to subtract at least 2–3 months from that benchmark.

0

|

0

ELTX·4 days agoStudy on track for success

If enrollment was allowed up to 6 months after chemo, wouldn’t it be more realistic to use an average adjustment of ~3 months to account for the timing gap between the reference points? Thanks in advance.

0

|

0